15 Most Shorted Stocks Right Now
The stock market has been volatile in the past few months as soaring inflation and rising rates combine to create an uncertain business environment in which growth stocks have taken a beating.
Pmv Pharmaceuticals Inc. (PMVP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,475,291 | $9,648,184 | 0.17% | |
| 2. | Sio Capital Michael Castor | 3,214,239 | $4,789,216 | +19% | 1.89% |
| 3. | Euclidean Capital Jim Simons | 2,627,643 | $3,915,188 | 0.43% | |
| 4. | Alkeon Capital Management Panayotis Takis Sparaggis | 2,343,731 | $3,492,160 | -1% | 0% |
| 5. | Partner Fund Management Christopher Medlock James | 2,011,040 | $2,996,450 | +58% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 55,555 | Large Shareholder, Director | 55,555 | 2020-09-25 | Filing | |
| $18.00 | 55,555 | Large Shareholder | 55,555 | 2020-09-25 | Filing | |
| $18.00 | 950,000 | Other | 950,000 | 2020-09-25 | Filing | |
| $18.00 | 475,000 | Large Shareholder, Director | 475,000 | 2020-09-25 | Filing | |
| $18.00 | 475,000 | Large Shareholder, Director | 475,000 | 2020-09-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 7,218 | 118,283 | 2024-09-11 | Filing | ||
| $1.50 | 2,891 | 88,395 | 2024-09-11 | Filing | ||
| $2.23 | 87,786 | Large Shareholder | 0 | 2023-11-22 | Filing | |
| $6.62 | 4,104 | Officer | 29,946 | 2023-09-15 | Filing | |
| $6.62 | 6,291 | Officer | 45,909 | 2023-09-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,930,340 | $12,184,054 | 0% | |
| 2. | 3,229,797 | $10,012,371 | 0% | |
| 3. | 2,714,143 | $8,413,843 | 0.09% | |
| 4. | 2,405,307 | $7,456,451 | 0% | |
| 5. | 1,580,487 | $4,899,510 | 0.03% |
News See All
10 Most Shorted Stocks in September
In the past two years, short squeezes have become a hot and a controversial topic on Wall Street.
10 Most Shorted Stocks to Watch in July
According to data shared by S3 Partners, short sellers increased their bets against the US stock market by $20 billion in June 2022.
Analysts Just Increased Price Targets of These 5 Stocks
In this article, we discuss 5 stocks that analysts just increased the price targets of.
5 Best Biotech and AI Stocks To Buy According To Billionaire Jim Simons
In this article, we discuss 5 stock picks of Jim Simons’ Euclidean Capital.
Do Hedge Funds Love PMV Pharmaceuticals, Inc. (PMVP)?
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
5 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
Below is the list of 5 pharmaceutical stocks to buy according to Jim Simons’ Euclidean Capital.
5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital
In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
Where Do Hedge Funds Stand On PMV Pharmaceuticals, Inc. (PMVP)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Is PMVP A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Billionaire Hedge Funds
